Table 1.

Frequency of selected HLA-DRB1 haplotypes in the NI-CINA patients

HaplotypePatients (%) (n = 56)Healthy controls (%) (n = 39)χ2-valuePvalue
HLA-DRB1*0101 4  (7.14) 2  (5.13) 0.9748 ns  
HLA-DRB1*0301 3  (5.36) 1  (2.56) 0.8827 ns  
HLA-DRB1*0701 12  (21.43) 6  (15.38) 0.6359 ns  
HLA-DRB1*1001 2  (3.57) 3  (7.69) 0.6761 ns  
HLA-DRB1*1101 10  (17.86) 12  (30.77) 0.2223 ns  
HLA-DRB1*1104 21  (37.5) 15  (38.46) 0.9045 ns  
HLA-DRB1*1201 2  (3.57) 2  (5.13) 0.8827 ns  
HLA-DRB1*1301 3  (5.36) 5  (12.82) 0.3612 ns  
HLA-DRB1*1302 12  (21.43) 1  (2.56) 5.4210 P = .0199  
HLA-DRB1*1401 5  (8.93) 6  (15.38) 0.5212 ns  
HLA-DRB1*1501 3  (5.36) 4  (10.26) 0.6171 ns  
HLA-DRB1*1502 4  (7.14) 3  (7.69) 0.7655 ns  
HLA-DRB1*1601 10  (17.86) 3  (7.69) 0.2650 ns 
HaplotypePatients (%) (n = 56)Healthy controls (%) (n = 39)χ2-valuePvalue
HLA-DRB1*0101 4  (7.14) 2  (5.13) 0.9748 ns  
HLA-DRB1*0301 3  (5.36) 1  (2.56) 0.8827 ns  
HLA-DRB1*0701 12  (21.43) 6  (15.38) 0.6359 ns  
HLA-DRB1*1001 2  (3.57) 3  (7.69) 0.6761 ns  
HLA-DRB1*1101 10  (17.86) 12  (30.77) 0.2223 ns  
HLA-DRB1*1104 21  (37.5) 15  (38.46) 0.9045 ns  
HLA-DRB1*1201 2  (3.57) 2  (5.13) 0.8827 ns  
HLA-DRB1*1301 3  (5.36) 5  (12.82) 0.3612 ns  
HLA-DRB1*1302 12  (21.43) 1  (2.56) 5.4210 P = .0199  
HLA-DRB1*1401 5  (8.93) 6  (15.38) 0.5212 ns  
HLA-DRB1*1501 3  (5.36) 4  (10.26) 0.6171 ns  
HLA-DRB1*1502 4  (7.14) 3  (7.69) 0.7655 ns  
HLA-DRB1*1601 10  (17.86) 3  (7.69) 0.2650 ns 

Yates continuity-corrected chi-square test. Statistically significant at P ≤ .05. ns, nonsignificant difference.

Proportions of haplotype-carrying subjects are in parentheses.

or Create an Account

Close Modal
Close Modal